Related by context. Frequent words. (Click for all words.) 62 Meets Primary Endpoint 61 ImmunoCellular Therapeutics 61 J. Donald deBethizy 60 Receives Orphan Drug Designation 60 Preclinical Development 59 Pulmonary Arterial Hypertension 59 Telbivudine 58 Dino Dina 58 Factor VIIa 58 Inflammatory Diseases 58 Æterna Zentaris 58 Clinical Trial Results 58 Initiates Phase II 57 Romark 57 Alinia 57 Sol J. Barer 57 Quark Pharmaceuticals 57 DDP# 57 Lung Rx 57 Cethromycin 57 Preclinical Data 57 KaloBios 57 Hepatitis C Virus 57 forodesine 57 Metabolic Disorders 57 Myelodysplastic Syndromes 57 Moxifloxacin 57 Presents Positive 57 Diabetic Macular Edema 57 Drug Candidate 57 Cardiometabolic 56 Synergy Pharmaceuticals 56 Kepivance 56 Emisphere Technologies 56 Antifungal 56 Aegera 56 II Clinical Trial 56 Mr. Fater 56 AFFiRiS 56 Hepatocellular Carcinoma 56 Inovio Pharmaceuticals 56 Guanilib 56 Onno van de Stolpe 56 Patient Enrollment 56 Cerus Corporation 55 Mucosal 55 Humanetics 55 THALOMID 55 Targeted Therapies 55 Acute Ischemic Stroke 55 Kiadis Pharma 55 Initiate Phase 55 Trofex 55 Panzem R 55 gets USFDA nod 55 Pivotal Study 55 VIRxSYS 55 Anticoagulant 55 Bioequivalence 55 CMV vaccine 55 Phase III Clinical Trial 55 FDA Clears 55 nosocomial pneumonia 55 Hematologic 55 Announces FDA Clearance 55 Steven A. Kriegsman 55 Pivotal Phase III 55 DermaVir 55 MultiCell Technologies 55 Overactive Bladder 55 TapImmune 55 Molecular Diagnostic 55 HepaLife Technologies Inc. 55 eniluracil 55 AEMD 55 oropharyngeal candidiasis 55 QLT# 55 Photodynamic Therapy 55 AVEO Pharmaceuticals 54 Novelos Therapeutics 54 Pulse Oximetry 54 daptomycin 54 Kauffman MD Ph.D. 54 PEG SN# 54 Intranasal 54 Phase Ib II 54 Significantly Improves 54 Daclizumab 54 Recombinant Human 54 Drug Shows Promise 54 Diagnostic Tests 54 Increlex ® 54 Edward Lanphier Sangamo 54 HuMax CD4 54 #:#-# [031] 54 SEPET TM 54 NovaBay Pharmaceuticals 54 Aliskiren 54 histone deacetylase HDAC inhibitor 54 Nanobiotix 54 Rifampicin